Estland -
Estlands -
Ravimiamet
sildenafil sandoz 100 mg tablett
sandoz pharmaceuticals d.d. - sildenafiil - tablett - 100mg 8tk; 100mg 1tk; 100mg 12tk; 100mg 16tk; 100mg 20tk; 100mg 4tk; 100mg 2tk; 100mg 10tk; 100mg 28tk
Estland -
Estlands -
Ravimiamet
sildenafil sandoz 100 mg tablett
lex ano uab - sildenafiil - tablett - 100mg 12tk; 100mg 4tk
Europese Unie -
Estlands -
EMA (European Medicines Agency)
kisplyx
eisai gmbh - lenvatinibmesülaat - kartsinoom, neerurakk - antineoplastilised ained - kisplyx is indicated for the treatment of adults with advanced renal cell carcinoma (rcc):in combination with pembrolizumab, as first-line treatment (see section 5. in combination with everolimus, following one prior vascular endothelial growth factor (vegf)-targeted therapy.
Europese Unie -
Estlands -
EMA (European Medicines Agency)
carmustine medac (previously carmustine obvius)
medac gesellschaft für klinische spezialpräparate mbh - carmustine - hodgkin disease; lymphoma, non-hodgkin - antineoplastilised ained - carmustine is indicated n adults in the following malignant neoplasms as a single agent or in combination with other antineoplastic agents and/or other therapeutic measures (radiotherapy, surgery): , brain tumours (glioblastoma, brain-stem gliomas, medulloblastoma, astrocytoma and ependymoma), brain metastases, secondary therapy in non-hodgkin’s lymphoma and hodgkin’s disease, as conditioning treatment prior to autologous haematopoietic progenitor cell transplantation (hpct) in malignant haematological diseases (hodgkin’s disease / non-hodgkin’s lymphoma).
Estland -
Estlands -
Ravimiamet
epirubicin kabi 2 mg/ml süste-/infusioonilahus
fresenius kabi oncology plc - epirubitsiin - süste-/infusioonilahus - 2mg 1ml 5ml 1tk; 2mg 1ml 50ml 1tk
Estland -
Estlands -
Ravimiamet
epirubicin actavis süstelahus
teva b.v. - epirubitsiin - süstelahus - 2mg 1ml 100ml 1tk; 2mg 1ml 5ml 1tk; 2mg 1ml 25ml 1tk; 2mg 1ml 10ml 1tk
Estland -
Estlands -
Ravimiamet
epirubicin teva süste-/infusioonilahus
teva pharma b.v. - epirubitsiin - süste-/infusioonilahus - 2mg 1ml 10ml 1tk; 2mg 1ml 75ml 1tk; 2mg 1ml 5ml 1tk; 2mg 1ml 25ml 1tk
Estland -
Estlands -
Ravimiamet
epirubicin accord süste-/infusioonilahus
accord healthcare b.v. - epirubitsiin - süste-/infusioonilahus - 2mg 1ml 50ml 1tk; 2mg 1ml 5ml 1tk; 2mg 1ml 25ml 1tk; 2mg 1ml 10ml 1tk
Estland -
Estlands -
Ravimiamet
fluorescite süstelahus
alcon farmaceutika d.o.o. - fluorestseiin - süstelahus - 100mg 1ml 5ml 12tk
Estland -
Estlands -
Ravimiamet
carmustine accord infusioonilahuse kontsentraadi pulber ja lahusti
accord healthcare b.v. - karmustiin - infusioonilahuse kontsentraadi pulber ja lahusti - 100mg 10tk; 100mg 1tk